Amphetamine cardiomyopathy
The Sympathomimetics page has been updated with additional information about the increasingly common amphetamine induced cardiomyopathy.
Dunn RJ
The Sympathomimetics page has been updated with additional information about the increasingly common amphetamine induced cardiomyopathy.
The section on GHB in the Other sedative hypnotics page has been revised and updated.
The Cocaine page has had a number of minor updates.
The Sympathomimetics page has been updated with some additional information about amphetamines.
The Illicit drug use page has been updated with an improved section on complications of IV drug use.
The Gout medications page has been updated with additional information about colchicine toxicity.
The Anticonvulsant toxicity page has been updated with some additional information about valproate levels.
Key points have been added to the Salicylate page.
The Salicylate page has had a number of minor updates.
The Sodium channel blocking agents page has been updated with some information about lipid emulsion therapy.
The Sodium channel blocking agents page has been updated with some additional information about HCO3 therapy.
Key points have been added to the Organophosphates page.
The Organophosphates page has had a number of minor updates.
Key points have been added to the Calcium channel antagonists page.
Key points have been added to the Beta blocker page.
The Beta blocker page has had a number of small updates.
The Calcium channel antagonists page has had a number of minor updates.
The Extracorporeal elimination of toxic compounds page has been updated, including a list of substances where it is of no benefit.
The Toxidromes page has been updated, including the addition of the serotoninergic toxidrome.
The Ethanol page has been corrected to indicate that metabolism is 1st order kinetics at lower concentrations and zero order kinetics at higher concentrations – instead of the other way around, as previously stated. Thanks to David for picking this up.